Pfizer PBC 125 Pill - tan capsule/oblong, 22mm
Generic Name: palbociclib
Pill with imprint Pfizer PBC 125 is Tan, Capsule/Oblong and has been identified as Ibrance 125 mg. It is supplied by Pfizer Inc.
Ibrance is used in the treatment of Breast Cancer, Metastatic; Breast Cancer; Breast Cancer, Male; Liposarcoma and belongs to the drug class CDK 4/6 inhibitors. Ibrance 125 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for Pfizer PBC 125
Ibrance
- Generic Name
- palbociclib
- Imprint
- Pfizer PBC 125
- Strength
- 125 mg
- Color
- Tan
- Size
- 22.00 mm
- Shape
- Capsule/Oblong
- Availability
- Prescription only
- Drug Class
- CDK 4/6 inhibitors
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Pfizer Inc.
- National Drug Code (NDC)
- 00069-0189
- Inactive Ingredients
-
microcrystalline cellulose,
lactose monohydrate,
sodium starch glycolate type A potato,
silicon dioxide,
magnesium stearate,
ferric oxide red,
ferric oxide yellow,
titanium dioxide,
shellac,
ammonia,
propylene glycol,
dimethicone
Note: Inactive ingredients may vary.
Related images for "Pfizer PBC 125"
More about Ibrance (palbociclib)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (85)
- Drug images
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Support group
- FDA approval history
- Drug class: CDK 4/6 inhibitors
- Breastfeeding
- En español
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.